Status report on neuropharmacology

Indian Journal of Pharmacology

Volumn 32, Issue 4, 2000, Pages

  Muruganandam, A V ^a   Kumar, V ^a   Bhattacharya, S K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIOXIDANT; ANTIPYRETIC ANALGESIC AGENT; ATRIAL NATRIURETIC FACTOR; BACOPA MONNIERI EXTRACT; CATECHOLAMINE; CENTRAL NERVOUS SYSTEM AGENTS; CHLORPROMAZINE; CHOLINERGIC RECEPTOR; CLOZAPINE; DIAZEPAM; DIZOCILPINE; ENKEPHALIN DERIVATIVE; HALOPERIDOL; ISATIN; MELATONIN; NEUROLEPTIC AGENT; NEUROSTEROID; NEUROTRANSMITTER; ONDANSETRON; PSYCHOTROPIC AGENT; SCOPOLAMINE BUTYL BROMIDE; SEROTONIN; SEROTONIN 3 ANTAGONIST; SUMATRIPTAN; TRIBULIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTICONVULSANT ACTIVITY; ANXIETY NEUROSIS; CENTRAL NERVOUS SYSTEM DISEASE; CHOLINERGIC ACTIVITY; COGNITIVE DEFECT; CONVULSION; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EXPERIMENTAL MODEL; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MEDICAL RESEARCH; MEDICINAL PLANT; MENTAL DISEASE; NONHUMAN; REVIEW; SLEEP DISORDER; TRANQUILIZING ACTIVITY;

EID: 0033822532     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (198)

1. Role of dopaminergic mechanisms in the regulation of stress responses in experimental animals
2. A differential dopamine receptor involvement during stress ulcer formation in rats
3. Involvement of dopaminergic mechanisms in racemate pentazocine induced stereotyped behaviour in rats
4. Effects of pentazocine on dopamine dependent behaviours in mice
5. Dose-dependent response of central dopaminergic systems to metoclopramide in mice
6. Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain
7. Baclofen-induced catatonia: Modification by serotonergic agents
8. Effects of drugs influencing central serotonergic mechanisms on pentazocine-induced catalepsy in mice
9. Effect of serotonergic agents on amphetamine induced stereotypy
10. Inhibition of 5-HT induced aggregation in melanophores of the wall lizard (Hemidactylus flaviviridis) by specific antagonist in in vitro
11. 3 receptors. A review of their pharmacologic and therapeutic aspects
12. 3 antagonist, in a novel animal model
13. Effect of ondansetron on short term memory retrieval in mice
14. 3 antagonist
15. Antinociceptive effect of sumitriptan in mice
16. Brain monoamines and metabolites during early streptozotocin-induced diabetes in rats
17. Species variation in the specificity of cholinesterases in human and rat blood samples
18. Correlation of time course of blood cholinesterase activity and toxic manifestations of acute methyl parathion in antidote treated rats
19. Correlation between the severity of symptoms in organophosphorus poisoning and cholinesterase activity (RBC and plasma) in human
20. Study of neuro-excitatory features during diazepam withdrawal reactions and their correlation with brain gamma amino butyric acid levels
21. International Union of Pharmacology. XII Classification of Opioid Receptors
22. The psychopharmacology of isatin: A brief review
23. Effects of some anxiogenic agents on rat brain monoamine oxidase (MAO) A and B inhibitory (tribulin) activity
24. Anxiogenic action of caffeine: An experimental study in rats
25. Anxiogenic action of centrally administered scorpion (Mesobuthus tamulus) venom in rats
26. Anxiogenic activity of intraventricularly administered bradykinin in rats
27. Anxiogenic action of intraventricularly administered arginine-vasopressin in the rat
28. Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy): An experimental study
29. Rat brain MAO-A and MAO-B inhibitory (tribulin) activity during drug withdrawal anxiety
30. Behavioural effects of isatin, a putative biological factor, in rhesus monkeys
31. Anxiolytic activity of intraventricularly administered atrial natriuretic peptide in the rat
32. Anticonvulsant activity of intraventricularly administered atrial natriuretic peptide and its inhibition by isatin
33. Isatin inhibits the memory facilitating effect of centrally administered atrial natriuretic peptide in the rats
34. Isatin, a putative anxiogenic endocoid, induces memory dysfunction in rats
35. Iron - ion catalyzed oxidation of tryptophan - A simulated biosynthetic route to isatin
36. Dose-related proconvulsant and anticonvulsant activity of isatin, a putative biological factor, in rats
37. 3 receptors
38. Neurosteroids: A new class of neuromodulators
39. Role of GABA(A) and mitochondrial diazepam binding inhibitor receptor in the ant-stress activity of neurosteroids in mice
40. Neuroprotective effects of neurosteroids against hypoxic stress-induced neurotoxicity in naive and FG 7142-treated mice
41. Neurosteroid co-administration prevent development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice
42. Chronic neurosteroid treatment prevents developments of morphine tolerance and attenuates abstenance behaviour in mice
43. Potential mechanisms of neurosteroid -induced attenuation of morphine tolerance and dependence
44. Differential anxiolytic effects of neurosteroids in the mirrored chamber behaviour test in mice
45. Reversal of benzodiazepine inverse agonist FG 7142 induced anxiety syndrome by neurosteroids in mice
46. Role of GABA(A) and mitochondrial diazepam binding inhibits receptors on the effects of neurosteroids on food intake in mice
47. Sex and oestrus cycle-dependent in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviours in rats
48. The effects of neurosteroids on acquisition and retention of a modified passive avoidance learning task in mice
49. Possible role of nitric oxide in the nootropic and anti-amnesic effects of neurosteroids on aging- and dizocilpine -induced learning impairment
50. Inhibition of neuronal nitric oxide synthase (n-cNOS) reverses the corticotropin induced behavioural effects in rats
51. Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice
52. Sigma (σ1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test
53. Behavioural pharmacology of melatonin
54. Evidence for GABA-ergic modulation of melatonin induced short-term memory deficits and food consumption
55. Central nervous depressant activities of melatonin in rats and mice
56. Regulation of secretion of II-4 and IgGl-isotope by melatonin stimulated ovalbumin specific T cells
57. Involvement of cholinergic system in losartan-induced facilitation of spatial and short term working memory
58. Modulations of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan
59. Differential effects of diazepam on anxiety in streptozotocin induced diabetes and non-diabetic rats
60. Behavioural effect of prenatal diazepam administration on anxiety pattern in rats
61. Vasopressin and atrial natriuretic peptide: From water homeostasis to behaviour
62. Stress and water balance: The roles of ANP, AVP and isatin
63. A primate model of anxiety
64. Model of anxiety in primates
65. Fear-potentiated poststartle activity in neonatal clomipramine treated rats
66. Effect of DSP-4 induced depletion of brain norepinephrine on appetitive and aversive memory retrieval
67. Involvement of muscarnic receptor in the retrieval of shock-motivated brightness discrimination response
68. Relationship between rate of administration of ECS - and rate of learning in rats: Implications for the practice of ECT
69. ECT-induced antrograde amnesia: Can the deficits be minimized
70. Evaluation of pre ECS-anti-hypertensive drug administration in the attenuation of ECS-induced retrograde amnesia
71. BR-16A protects against ECS-induced antrograde amnesia
72. BR-16A attenuates antrograde amnesia induced by electroconvulsive shock in slow learning in rats
73. Changes in learning and memory, acetyl cholinesterase activity and monoamines in the brain after chronic carbamazepine administration in rats
74. Effects of ACTH and ACTH 4-10 on aversive memory retrieval in rats
75. Effect of central administration of arginine-vasopressin on aversive memory retrieval
76. Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats
77. Effect of central administration of oxytocin on appetitive and aversive memory retrieval
78. Effect of p-chlorophenyl alanine-induced depletion of brain serotonin on retrieval of appetitive and aversive memories
79. Effect of some psychotropic agents on cognitive functions in rats
80. Scopalamine blocks the effects of swim stress on memory retrieval in rats
81. Chronic phenytoin induces impairment of learning and memory with associated changes in brain acetyl choline esterase activity and monoamine levels
82. Phenytoin and phenobarbital: A comparison of their state dependent effects
83. 2 adrenoreceptor agonist in mice
84. Determination of anticonvulsant effects on seizure thresholds using ramp generated cortical stimulation in young rats
85. Influence of adenosine, dipyridamol, adenosine antagonists and antiepileptic drugs on EEG after discharge following cortical stimulation
86. Kindling model of epilepsy
87. Lithium-pilocarpine neurotoxicity: A potential model of status epilepticus
88. Protective effects of GABA-ergic drugs and other anti-convulsive in lithium-pilocarpine-induced status epilepticus
89. Modulation of lithium-pilocarpine-induced status epilepticus by adenosinergic agents
90. Protective effect of clozapine against pentylenetetrazol convulsions and kindling
91. Development of self sustaining limbic status epilepticus by continuous ventral hippocampal stimulation followed by low dose pilocarpine in rats
92. Current concepts in molecular diversity and pharmacology of dopamine receptors
93. 2 receptors in dopamine depleted animals
94. 2 receptors !
95. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA-antagonist MK-801
96. 5-HT(2A) receptor antagonists block MK-801-induced stereotypy and hyperlocomotion
97. Dopamine receptor sensitive effect of dizocilpine on feeding behaviour
98. Clozapine-induced cognitive dysfunction's in mice
99. Antimuscarinic effects of clozapine in rats
100. Comparative effects of hyoscine butyl bromide and atropine sulphate on sleep architecture in healthy human volunteers
101. Effect of hyoscine butyl bromide and atropine on heart rate during nocturnal sleep
102. Effect of the karnatic music raga 'Neelambari' on sleep architecture
103. Establishing a polysomnography laboratory in India: Problems and pitfalls
104. Sleep medicine - An emerging medical specialty
105. Novel met-enkephalin analogue; A potent systemic Mu agonist antinociceptive agent
106. Synthesis and analgesic activity of dermorphin analogues
107. Synthesis and opioid activity of novel tetrapeptides analogues to sequence (1-4) of dermorphin
108. Synthesis and opioid activity of novel dermorphin related heptapeptides
109. Synthesis anti-inflammatory and analgesic activity evaluation of some 2-(9-acridinylamino) pyridines and (2-9-acridinylamine/imino) thiazolines
110. Nature of neurotransmitters involved in pretectal stimulation produced analgesia
111. Antinociception induced by neurotransmitter agonists microinjected into the pretectal nucleus of rat
112. Possible involvement of nitric oxide in red nucleus stimulation-induced analgesia in the rat
113. Neurohumoral modulation of analgesia
114. The role of arginine EDRF/NO pathway in cardiovascular regulation of cat
115. Regulation of blood brain barrier nitric oxide
116. Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium
117. Nitric oxide-dependent blood-brain barrier permeability alteration in the rat brain
118. Permeability function in relation to cerebral microvessel enzymes during aging in rats
119. Interrelationship between blood pressure level and brain nitric oxide synthase (NOS) activity in rats
120. Role of endogenous cyclo (His-Pro) in cold induced hypothermia in desert rat (Mastomys natalensis)
121. Cyclo (His-Pro) modulation of body temperature at hot ambient temperature in the desert rat (Mastomys natalensis)
122. Attenuation of alcohol induced hypothermia by cyclo (His-Pro) and its analogs
123. Effect of 2-N (substituted) amino-pyrido [1,2-9] pyrimidin-4-oxo-1H-3-carboniriles on the analgesic activity in albino mice
124. Synthesis and biological activities of 2-(N-substituted aminoethyl)-1,3-diphenyl-3-(4-methoxyphenyl)-propane 1,3-diones
125. N-(4-benzylidine-2-methyl/phenyl-5-oxo-imidazolin-1-yl)-acetamides and their-(-4-substituted) azo analogs
126. Activity profile of two hyperforin-containing Hypericum extracts in behavioural models
127. Hyperforin as a possible antidepressant component of hypericum extracts
128. Anxiolytic activity of standardised extracts of Bacopa monniera: An experimental study
129. Anxiolytic activity of Azadirachta indica leaf extract in rats
130. The chemistry and actions of 6-alkysalcylates of Indian Ginkgo biloba
131. Anxiolytic activity of ginkgolic acid conjugates from Indian Ginkgo biloba
132. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer's disease and perturbed cholinergic markers of cognition in rats
133. Effect of Trasina®, an Ayurvedic herbal formulation, on experimental models of Alzheimer's disease and central cholinergic markers in rats
134. Effect of Mentat, a herbal formulation, on experimental models of Alzheimers' disease and central cholinergic markers in rats
135. Effect of Lawsonia inermis on memory and behaviour mediated via neurotransmitters
136. Antioxidant activity of glycowithanolides from Withania somnifera
137. Antioxidant activity of Ocimum sanctrum: An experimental study
138. Antioxidant defense by native and processed Shilajit: A comparative study
139. Effects of Shilajit on biogenic free radicals
140. Experimental evaluation of the antistress activity of a herbal formulation Zeetress
141. The anti-stress activity of gem-containing Unani formulation against diverse stressors
142. Neuropharmacological studies on Panex ginseng
143. CNS activity of Cassia fistula in mice
144. CNS activity of petroleum ether extract of Vitex negundo Linn in mice
145. Effect of Nardostachys jatamansi on biogenic amines and inhibitory amino acids in rat brain
146. Analgesic activity of gold preparation used in Ayurved and Unani-TIBB
147. Gold preparations used in Ayurveda and Unani-TIBB, therapeutic rationale and safety aspect
148. Analgesic activity of Bacosine, a new triterpine isolated from Bacopa monnieri
149. Antinociceptive action of Azadirachta indica (neem) in mice: Possible mechanisms involved
150. Preliminary behavioural and neurological studies on Kushta Marjan and Kushta Khar Mohara used in Unani-TIBB
151. Anti-epileptic and anti-cancer activity of some indigenous plants
152. Amygdaloid kindling in rats: Protective effect of W.somnifera root extract
153. Anticonvulsant action of W. somnifera root extract against PTZ-induced kindling in mice
154. Neuroprotection by Withania somnifera root extract against lithium-pilocarpine-induced seizures
155. Protective effect of Withania somnifera root extract on electrographic activity in lithium-pilocarpine model of status epilepticus
156. Pentylenetetrazol-induced kindling in animals: Protective effect of BR-16A
157. Anticonvulsant profile of Siotone granules®, a herbal preparation
158. Reversal of diazepam induced withdrawal hyperactivity in mice by BR-16A (Mentat®), a herbal preparation
159. Triazolam withdrawal-induced hyperactivity and anxiety in mice: Prevention by BR-16A, a herbal psychotropic formulation
160. Inhibition of tolerance and dependence to opiate by Withania somnifera in mice
161. Psychopharmacological profile of Siotone granules, a herbal psychotropic preparation
162. Reversal of forced swimming-induced chronic fatigue in mice by antidepressant and herbal psychotropic drugs
163. Gastric antiulcer activity of UL-409 in rats
164. Spirulina-induced hyperlocomotor activity and stereotypy in mice
165. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and shilajit differentially affects cholinergic but not glutaminergic and gabaergic markers in rat brain
166. Effects of ginkgolic acid conjugates on the brain monoamines and metabolites in rodents
167. Effect of Wrightia tinctoria on the brain monoamines and metabolites in rats
168. Neuropharmacological studies on Fusarium toxins, I. Total toxin extract from F. moniliforme
169. Neuropharmacological studies on Fusarium toxins, II. Total toxin extract from F. oxysporum
170. Neuropharmacological studies on Fusarium toxins, III. Neurochemical investigations on total toxin extract from F. moniliforme and F. oxysporum
171. Modulation of acrylamide-induced neurochemical and behavioural deficits by cerebellar transplantation in rats
172. Effect of protein malnutrition on the neurobehavioural toxicity of styrene in young rats
173. Neurobehavioural, neurochemical and electrophysiological studies in 6-hydroxydopamine lesional and neural transplanted rats
174. Influence of iron deficiency and lead treatment on behaviour and cerebellar and hipocampal polyamine levels in neonatal rats
175. Cadmium induced alterations in blood-brain barrier permeability and its possible correlation with microvessal antioxidant potential in rat
176. Restoration of trimethyltin induced hippocampal degeneration of single and multiple transplantation
177. Cholinergic and serotonergic alterations in the rat hippocampus following tirmethyltin exposure and fetal neural transplantation
178. Behavioural, neurochemical and neuromorphological effects of deltamethrin in adult rats
179. Use of toxic metals in Indian system of medicine: Therapeutic rationale and safety aspects
180. Neurobehavioural neurochemical and electrophysiological studies in 6-hydroxydopamine lesioned and neural transplanted rats
181. Nitric oxide modulation of cardiovascular responses from ventral surface of medulla in cat
182. Interaction of ciprofloxacin with diclofenac and paracetamol in relation to its epileptogenic effect
183. Synergistic effect of flunarizine and sodium valproate on seizure threshold elicited by cortical stimulation in conscious rats
184. Additive anticonvulsant effect of flunarizine and sodium valproate on electroshock and chemoshock induced seizures in mice
185. Behavioural alterations in rats induced by single prenatal exposure of haloperidol
186. Effect of prenatal haloperidol administration on anxiety patterns in rats
187. Effect of prenatal undernutrition and phenobarbitone administration on discrimination learning and passive avoidance behaviour in rats
188. Experimental methods for the evaluation of psychotropic drugs in rats. Antianxiety agents
189. Experimental methods for evaluation of psychotropic agents: II Antidepressants
190. New targets for novel analgesics
191. Analgesics: New vistas
192. Rationale management of postoperative pain in children
193. Rationale use of analgesic for acute and post operative pain in children
194. Recent approaches to pharmacological management of senile dementia
195. Selective serotonin re-uptake inhibitors: Clinical use in psychiatry
196. Sumitriptan: A new drug for migraine and cluster headache
197. The blood-brain barrier: Some recent developments